The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
Open accessAbstract
Interleukin 10 (IL-10) and viral IL-10 (v-IL-10) strongly reduced antigen-specific proliferation of human T cells and CD4+ T cell clones when monocytes were used as antigen-presenting cells. In contrast, IL-10 and v-IL-10 did not affect the proliferative responses to antigens presented by autologous Epstein-Barr virus-lymphoblastoid cell line (EBV-LCL). Inhibition of antigen-specific T cell responses was associated with downregulation of constitutive, as well as interferon gamma- or IL-4-induced, class II MHC expression on monocytes by IL-10 and v-IL-10, resulting in the reduction in antigen-presenting capacity of these cells. In contrast, IL-10 and v-IL-10 had no effect on class II major histocompatibility complex (MHC) expression on EBV-LCL. The reduced antigen-presenting capacity of monocytes correlated with a decreased capacity to mobilize intracellular Ca2+ in the responder T cell clones. The diminished antigen-presenting capacities of monocytes were not due to inhibitory effects of IL-10 and v-IL-10 on antigen processing, since the proliferative T cell responses to antigenic peptides, which did not require processing, were equally well inhibited. Furthermore, the inhibitory effects of IL-10 and v-IL-10 on antigen-specific proliferative T cell responses could not be neutralized by exogenous IL-2 or IL-4. Although IL-10 and v-IL-10 suppressed IL-1 alpha, IL-1 beta, tumor necrosis factor alpha (TNF-alpha), and IL-6 production by monocytes, it was excluded that these cytokines played a role in antigen-specific T cell proliferation, since normal antigen-specific responses were observed in the presence of neutralizing anti-IL-1, -IL-6, and -TNF-alpha mAbs. Furthermore, addition of saturating concentrations of IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha to the cultures had no effect on the reduced proliferative T cell responses in the presence of IL-10, or v-IL-10. Collectively, our data indicate that IL-10 and v-IL-10 can completely prevent antigen-specific T cell proliferation by inhibition of the antigen-presenting capacity of monocytes through downregulation of class II MHC antigens on monocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,865
Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI
Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A., & Mosmann, T. R. (1990) · Science · doi:10.1126/science.2161559 · Cited by 1,143
Expression and secretion of type beta transforming growth factor by activated human macrophages.
Assoian, R. K., Fleurdelys, B. E., Stevenson, H. C., Miller, P. J., Madtes, D. K., Raines, E. W., Ross, R., & Sporn, M. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.17.6020 · Cited by 970
Vieira, P., de Waal-Malefyt, R., Dang, M. N., Johnson, K. E., Kastelein, R., Fiorentino, D. F., deVries, J. E., Roncarolo, M. G., Mosmann, T. R., & Moore, K. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1172 · Cited by 739
Self-citationStructure and Function of Leukocyte Integrins
Larson, R. S., & Springer, T. A. (1990) · Immunological Reviews · doi:10.1111/j.1600-065x.1990.tb00565.x · Cited by 599
Expression of Interleukin-10 Activity by Epstein-Barr Virus Protein BCRF1
Hsu, D.-H., Malefyt, R. D. W., Fiorentino, D. F., Dang, M.-N., Vieira, P., deVries, J., Spits, H., Mosmann, T. R., & Moore, K. W. (1990) · Science · doi:10.1126/science.2173142 · Cited by 535
Self-citationSimultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones.
Paliard, X., de Waal Malefijt, R., Yssel, H., Blanchard, D., Chrétien, I., Abrams, J., de Vries, J., & Spits, H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.3.849 · Cited by 512
Self-citationInterleukin 10: a novel stimulatory factor for mast cells and their progenitors.
Thompson-Snipes, L., Dhar, V, Bond, M. W., Mosmann, T. R., Moore, K. W., & Rennick, D. M. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.2.507 · Cited by 495
Scheurich, P., Thoma, B., Ucer, U., & Pfizenmaier, K. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.6.1786 · Cited by 492
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Self-citationA CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Self-citationThe Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
WONG, C. K., LAM, C. W. K., WU, A. K. L., IP, W. K., LEE, N. L. S., CHAN, I. H. S., LIT, L. C. W., HUI, D. S. C., CHAN, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,274
Macrophage deactivation by interleukin 10.
Bogdan, C., Vodovotz, Y., & Nathan, C. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1549 · Cited by 1,238
T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
Raphael, I., Nalawade, S., Eagar, T. N., & Forsthuber, T. G. (2015) · Cytokine · doi:10.1016/j.cyto.2014.09.011 · Cited by 1,160
Sex hormones and the immune response in humans
Bouman, A., Heineman, M. J., & Faas, M. M. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi008 · Cited by 1,131
Biology and therapeutic potential of interleukin-10
Saraiva, M., Vieira, P., & O’Garra, A. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190418 · Cited by 1,118
IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation
Ouyang, W., & O’Garra, A. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.020 · Cited by 1,072
Sir Isaac Newton, sepsis, SIRS, and CARS
Bone, R. C. (1996) · Critical Care Medicine · doi:10.1097/00003246-199607000-00010 · Cited by 989
Sabat, R., Grütz, G., Warszawska, K., Kirsch, S., Witte, E., Wolk, K., & Geginat, J. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.09.002 · Cited by 977
Verreck, F. A. W., de Boer, T., Langenberg, D. M. L., Hoeve, M. A., Kramer, M., Vaisberg, E., Kastelein, R., Kolk, A., de Waal-Malefyt, R., & Ottenhoff, T. H. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400983101 · Cited by 977
Self-citationInterleukin-10 Therapy—Review of a New Approach
Asadullah, K., Sterry, W., & Volk, H. D. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.4 · Cited by 946
Stenvinkel, P., Ketteler, M., Johnson, R. J., Lindholm, B., Pecoits-Filho, R., Riella, M., Heimbürger, O., Cederholm, T., & Girndt, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00200.x · Cited by 932
Type 1/Type 2 Immunity in Infectious Diseases
Spellberg, B., & Edwards, J. E. (2001) · Clinical Infectious Diseases · doi:10.1086/317537 · Cited by 911
Viral Subversion of the Immune System
Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J., & Ploegh, H. L. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.861 · Cited by 835
Awasthi, A., Carrier, Y., Peron, J. P. S., Bettelli, E., Kamanaka, M., Flavell, R. A., Kuchroo, V. K., Oukka, M., & Weiner, H. L. (2007) · Nature Immunology · doi:10.1038/ni1541 · Cited by 804
“IL-10, a potent anti-inflammatory cytokine, 'antagonizes' T H 1 responses by inhibiting the production of interferon-γ (IFN-γ”
BackgroundT cell responses in patients with COVID-19
Chen, Z., & John Wherry, E. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0402-6 · Cited by 797
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., O’Mahony, L., Palomares, O., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 778
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.
Groux, H., Bigler, M., de Vries, J. E., & Roncarolo, M. G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.19 · Cited by 777
Self-citationInflammatory Mediators of Asthma: An Update
Barnes, P. J., Chung, K. F., & Page, C. P. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01381-4 · Cited by 717
Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma
Hawrylowicz, C. M., & O'Garra, A. (2005) · Nature Reviews Immunology · doi:10.1038/nri1589 · Cited by 683
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
Lucey, D. R., Clerici, M., & Shearer, G. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.532 · Cited by 666
Biological properties of interleukin 10
Howard, M., & O'Garra, A. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90153-x · Cited by 640
Chung, K. F., & Barnes, P. J. (1999) · Thorax · doi:10.1136/thx.54.9.825 · Cited by 638
The signal pathways and treatment of cytokine storm in COVID-19
Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 603
Effect of interleukin‐10 on dendritic cell maturation and function
de Smedt, T., van Mechelen, M., De Becker, G., Urbain, J., Leo, O., & Moser, M. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270526 · Cited by 565
Gregori, S., Tomasoni, D., Pacciani, V., Scirpoli, M., Battaglia, M., Magnani, C. F., Hauben, E., & Roncarolo, M.-G. (2010) · Blood · doi:10.1182/blood-2009-07-234872 · Cited by 561
Self-citationImmunoregulatory role of interleukin 10 in rheumatoid arthritis.
Katsikis, P. D., Chu, C. Q., Brennan, F. M., Maini, R. N., & Feldmann, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1517 · Cited by 529
James, J. A., Kaufman, K. M., Farris, A. D., Taylor-Albert, E., Lehman, T. J., & Harley, J. B. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119856 · Cited by 522
Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10)
Kotenko, S. V., Saccani, S., Izotova, L. S., Mirochnitchenko, O. V., & Pestka, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1695 · Cited by 519
Bogdan, C., Paik, J., Vodovotz, Y., & Nathan, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50091-0 · Cited by 512
Steinbrink, K., Jonuleit, H., Müller, G., Schuler, G., Knop, J., & Enk, A. H. (1999) · Blood · doi:10.1182/blood.v93.5.1634 · Cited by 511
Properties and Functions of Interleukin-10
Mosman, T. R. (1994) · Advances in Immunology · doi:10.1016/s0065-2776(08)60449-6 · Cited by 500
Allavena, P., Piemonti, L., Longoni, D., Bernasconi, S., Stoppacciaro, A., Ruco, L., & Mantovani, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01<359::aid-immu359>3.0.co;2-4 · Cited by 486
REGULATION OF MHC CLASS II GENES: Lessons from a Disease
Mach, B., Steimle, V., Martinez-Soria, E., & Reith, W. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.301 · Cited by 486
Cytokines in Inflammatory Bowel Disease
Rogler, G., & Andus, T. (1998) · World Journal of Surgery · doi:10.1007/s002689900401 · Cited by 484
Said, E. A., Dupuy, F. P., Trautmann, L., Zhang, Y., Shi, Y., El-Far, M., Hill, B. J., Noto, A., Ancuta, P., Peretz, Y., et al. (2010) · Nature Medicine · doi:10.1038/nm.2106 · Cited by 481
The paradoxical role of IL-10 in immunity and cancer
Mannino, M. H., Zhu, Z., Xiao, H., Bai, Q., Wakefield, M. R., & Fang, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.009 · Cited by 473
Clerici, M., Hakim, F. T., Venzon, D. J., Blatt, S., Hendrix, C. W., Wynn, T. A., & Shearer, G. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116294 · Cited by 469
Stumbles, P. A., Thomas, J. A., Pimm, C. L., Lee, P. T., Venaille, T. J., Proksch, S., & Holt, P. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2019 · Cited by 465
Stolina, M., Sharma, S., Lin, Y., Dohadwala, M., Gardner, B., Luo, J., Zhu, L., Kronenberg, M., Miller, P. W., Portanova, J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.361 · Cited by 465
Llorente, L., Richaud-Patin, Y., García-Padilla, C., Claret, E., Jakez-Ocampo, J., Cardiel, M. H., Alcocer-Varela, J., Grangeot-Keros, L., Alarcón-Segovia, D., Wijdenes, J., et al. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200008)43:8<1790::aid-anr15>3.0.co;2-2 · Cited by 461
Determinant spreading and the dynamics of the autoimmune T-cell repertoire
Lehmann, P. V., Sercarz, E. E., Forsthuber, T., Dayan, C. M., & Gammon, G. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90163-f · Cited by 461
Sjögren’s syndrome: a systemic autoimmune disease
Negrini, S., Emmi, G., Greco, M., Borro, M., Sardanelli, F., Murdaca, G., Indiveri, F., & Puppo, F. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-021-00728-6 · Cited by 459
Targeting cytokine and chemokine signaling pathways for cancer therapy
Yi, M., Li, T., Niu, M., Zhang, H., Wu, Y., Wu, K., & Dai, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01868-3 · Cited by 455
Strategies for use of IL‐10 or its antagonists in human disease
O'Garra, A., Barrat, F. J., Castro, A. G., Vicari, A., & Hawrylowicz, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00635.x · Cited by 452
Chronic inflammation and asthma
Murdoch, J. R., & Lloyd, C. M. (2010) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2009.09.005 · Cited by 443
Wong, C. K., Ho, C. Y., Ko, F. W. S., Chan, C. H. S., Ho, A. S. S., Hui, D. S. C., & Lam, C. W. K. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2001.01602.x · Cited by 440
Reversibility of T helper 1 and 2 populations is lost after long-term stimulation.
Murphy, E., Shibuya, K., Hosken, N., Openshaw, P., Maino, V, Davis, K., Murphy, K., & O'Garra, A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.901 · Cited by 435
IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes.
Lacraz, S., Nicod, L. P., Chicheportiche, R., Welgus, H. G., & Dayer, J. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118286 · Cited by 435
Papiernik, M. (1998) · International Immunology · doi:10.1093/intimm/10.4.371 · Cited by 434
Lyke, K. E., Burges, R., Cissoko, Y., Sangare, L., Dao, M., Diarra, I., Kone, A., Harley, R., Plowe, C. V., Doumbo, O. K., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.5630-5637.2004 · Cited by 434
Interleukin 10 production correlates with pathology in human Leishmania donovani infections.
Ghalib, H. W., Piuvezam, M. R., Skeiky, Y. A., Siddig, M., Hashim, F. A., el-Hassan, A. M., Russo, D. M., & Reed, S. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116570 · Cited by 434
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.
Uyemura, K., Demer, L. L., Castle, S. C., Jullien, D., Berliner, J. A., Gately, M. K., Warrier, R. R., Pham, N., Fogelman, A. M., & Modlin, R. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118650 · Cited by 427
Lack of Evidence for the Dichotomy of T H 1 and T H 2 Predominance in HIV-Infected Individuals
Graziosi, C., Pantaleo, G., Gantt, K. R., Fortin, J.-P., Demarest, J. F., Cohen, O. J., Sékaly, R. P., & Fauci, A. S. (1994) · Science · doi:10.1126/science.8023143 · Cited by 424
Bacchetta, R., Bigler, M., Touraine, J. L., Parkman, R., Tovo, P. A., Abrams, J., de Waal Malefyt, R., de Vries, J. E., & Roncarolo, M. G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.493 · Cited by 416
Self-citationDonnelly, R. P., Dickensheets, H., & Finbloom, D. S. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313695 · Cited by 413
Edwards-Smith, C. J., Jonsson, J. R., Purdie, D. M., Bansal, A., Shorthouse, C., & Powell, E. E. (1999) · Hepatology · doi:10.1002/hep.510300207 · Cited by 404
Role of cytokines in determining T-lymphocyte function
O'Garra, A., & Murphy, K. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90128-7 · Cited by 393
Immunosuppressive and Anti-inflammatory Properties of Interleukin 10
de Vries, J. E. (1995) · Annals of Medicine · doi:10.3109/07853899509002465 · Cited by 391
Self-citationClerici, M., Wynn, T. A., Berzofsky, J. A., Blatt, S. P., Hendrix, C. W., Sher, A., Coffman, R. L., & Shearer, G. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117031 · Cited by 390
Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge
Knoll, P., Schlaak, J., Uhrig, A., Kempf, P., zum Büschenfelde, K.-H. M., & Gerken, G. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80433-1 · Cited by 384
Harizi, H., Juzan, M., Pitard, V., Moreau, J.-F., & Gualde, N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2255 · Cited by 384
BOGDAN, C., & NATHAN, C. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb35934.x · Cited by 384
Cunha, F. Q., Mohcada, S., & Liew, F. Y. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91852-h · Cited by 383
Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytes
Willems, F., Marchant, A., Delville, J., Gérard, C., Delvaux, A., Velu, T., De Boer, M., & Goldman, M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240435 · Cited by 376
Inhibitory and Stimulatory Effects of IL-10 on Human CD8+ T Cells
Groux, H., Bigler, M., de Vries, J. E., & Roncarolo, M.-G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3188 · Cited by 376
Self-citationHesse, M., Piccirillo, C. A., Belkaid, Y., Prufer, J., Mentink-Kane, M., Leusink, M., Cheever, A. W., Shevach, E. M., & Wynn, T. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3157 · Cited by 369
Interleukin‐10 prevents experimental allergic encephalomyelitis in rats
Rott, O., Fleischer, B., & Cash, E. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240629 · Cited by 367
Dendritic cell-mediated T cell polarization
de Jong, E. C., Smits, H. H., & Kapsenberg, M. L. (2005) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0167-1 · Cited by 367
Fadok, V. A., Bratton, D. L., Guthrie, L., & Henson, P. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6847 · Cited by 366
Anergic T Cells as Suppressor Cells in Vitro
Lombardi, G., Sidhu, S., Batchelor, R., & Lechler, R. (1994) · Science · doi:10.1126/science.8202711 · Cited by 366
Abrams, J. S., Roncarolo, M., Yssel, H., Andersson, U., Gleich, G. J., & Silver, J. E. (1992) · Immunological Reviews · doi:10.1111/j.1600-065x.1992.tb01406.x · Cited by 362
Self-citationT cells and adaptive immunity to Mycobacterium tuberculosis in humans
Jasenosky, L. D., Scriba, T. J., Hanekom, W. A., & Goldfeld, A. E. (2015) · Immunological Reviews · doi:10.1111/imr.12274 · Cited by 362
Murphy, E. E., Terres, G., Macatonia, S. E., Hsieh, C. S., Mattson, J., Lanier, L., Wysocka, M., Trinchieri, G., Murphy, K., & O'Garra, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.223 · Cited by 360
Kubin, M., Kamoun, M., & Trinchieri, G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.211 · Cited by 358
Effects of cytokines on mycobacterial phagosome maturation
Via, L. E., Fratti, R. A., McFalone, M., Pagán-Ramos, E., Deretic, D., & Deretic1, V. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.7.897 · Cited by 356
Roncarolo, M. G., Gregori, S., Bacchetta, R., Battaglia, M., & Gagliani, N. (2018) · Immunity · doi:10.1016/j.immuni.2018.12.001 · Cited by 355
Self-citationOswald, I. P., Wynn, T. A., Sher, A., & James, S. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8676 · Cited by 353
Biological properties of interleukin 10
Howard, M., O'Garra, A., Ishida, H., de Waal Malefyt, R., & De Vries, J. (1992) · Journal of Clinical Immunology · doi:10.1007/bf00918147 · Cited by 348
Self-citationHuman placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10.
Roth, I., Corry, D. B., Locksley, R. M., Abrams, J. S., Litton, M. J., & Fisher, S. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.539 · Cited by 342
Levy, Y., & Brouet, J. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116977 · Cited by 340
The molecular profile of microglia under the influence of glioma
Li, W., & Graeber, M. B. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos116 · Cited by 340
Hong, Y. H., Lillehoj, H. S., Lee, S. H., Dalloul, R. A., & Lillehoj, E. P. (2006) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2006.07.007 · Cited by 332
Liew, F. Y., & O'Donnell, C. A. (1993) · Advances in Parasitology · doi:10.1016/s0065-308x(08)60208-0 · Cited by 332
Reversal of Proinflammatory Responses by Ligating the Macrophage Fcγ Receptor Type I
Sutterwala, F. S., Noel, G. J., Salgame, P., & Mosser, D. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.217 · Cited by 327
Immune defects observed in patients with primary malignant brain tumors
Dix, A. R., Brooks, W. H., Roszman, T. L., & Morford, L. A. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00203-9 · Cited by 323
Potent Immunosuppressive Activities of Cytomegalovirus- Encoded Interleukin-10
Spencer, J. V., Lockridge, K. M., Barry, P. A., Lin, G., Tsang, M., Penfold, M. E. T., & Schall, T. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1285-1292.2002 · Cited by 322
Epithelial cell proliferation and islet neogenesis in IFN-g transgenic mice
Gu, D., & Sarvetnick, N. (1993) · Development · doi:10.1242/dev.118.1.33 · Cited by 321
Proinflammatory Effects of IL-10 During Human Endotoxemia
Lauw, F. N., Pajkrt, D., Hack, C. E., Kurimoto, M., van Deventer, S. J. H., & van der Poll, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2783 · Cited by 318
de Waal Malefyt, R., Hans, Y., Roncarolo, M.-G., Spits, H., & de Vries, J. E. (1992) · Current Opinion in Immunology · doi:10.1016/0952-7915(92)90082-p · Cited by 312
Self-citationMa, W., Lim, W., Gee, K., Aucoin, S., Nandan, D., Kozlowski, M., Diaz-Mitoma, F., & Kumar, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011157200 · Cited by 308
Koppelman, B., Neefjes, J. J., de Vries, J. E., & de Waal Malefyt, R. (1997) · Immunity · doi:10.1016/s1074-7613(00)80404-5 · Cited by 307
Self-citationMatsuda, M., Salazar, F., Petersson, M., Masucci, G., Hansson, J., Pisa, P., Zhang, Q. J., Masucci, M. G., & Kiessling, R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2371 · Cited by 306
T cell anergy and costimulation
Appleman, L. J., & Boussiotis, V. A. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00009.x · Cited by 305
Interleukin 10 Receptor Signaling
Shouval, D. S., Ouahed, J., Biswas, A., Goettel, J. A., Horwitz, B. H., Klein, C., Muise, A. M., & Snapper, S. B. (2014) · Advances in Immunology · doi:10.1016/b978-0-12-800267-4.00005-5 · Cited by 304
Targeting IL-10 Family Cytokines for the Treatment of Human Diseases
Wang, X., Wong, K., Ouyang, W., & Rutz, S. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028548 · Cited by 302
Impaired antigen presentation by human monocytes during endotoxin tolerance
Wolk, K., Döcke, W.-D., von Baehr, V., Volk, H.-D., & Sabat, R. (2000) · Blood · doi:10.1182/blood.v96.1.218 · Cited by 300
Metadata
- Authors
- de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., & de Vries, J. E.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1991-10-01
- Volume
- 174
- Issue
- 4
- Pages
- 915-924
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2101771134
- Cited by
- 1,930
- References
- 28
- FWCI
- 25.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.